Physician profile
Gleen Go
NPI 1083649529
$766.76
in general payments reported to CMS, 2019-2025
7 companies · $45.07 in 2025
The $45.07 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $91.28 · 2021: $185 · 2022: $15.39 · 2023: $193 · 2024: $81.29 · 2025: $45.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $168.79 | 2019-2023 | Dificid, Recarbrio, Zerbaxa |
| Pfizer INC. | $163.02 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $145.94 | 2019-2021 | |
| Abbvie INC. | $125.81 | 2021-2023 | |
| Shionogi INC | $113.06 | 2023-2025 | Fetroja |
| Melinta Therapeutics, LLC | $25.51 | 2019 | |
| Allergan, INC. | $24.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gleen Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.